AMI Cardiogenic Shock
Early Stabilization Can Improve Outcomes in Cardiogenic Shock
Impella® heart pumps have the ability to stabilize patient hemodynamics, unload the left ventricle, perfuse end organs, and allow for recovery of the native heart in patients with ongoing cardiogenic shock. Identifying patients early, treating them with a proven protocol, and following them with hemodynamic monitoring and aggressive down titration of inotropes and vasopressors can reverse the downward spiral of cardiogenic shock and help patients achieve myocardial recovery.
Explore the Education Library
Using the National Cardiogenic Shock Initiative (NCSI) Study Algorithm
Inder Singh, MD, describes evaluating the patient with respect to a cardiogenic shock algorithm.
Achieving >70% AMI Cardiogenic Shock Survival: Insight from National Cardiogenic Shock Initiative (NCSI) Study
William O'Neill, MD, explains how cardiac power output (CPO) and pulmonary artery pulsatility index (PAPI) are used to drive care for patients after angioplasty.
Implementing a Cardiogenic Shock Protocol to Improve Outcomes
Alexander Truesdell, MD, and Benham Tehrani, MD, discuss implementing a cardiogenic shock protocol.
Resources for Health Care Professionals
Learn more about how identifying patients early and adhering to a best practice protocol can help patients achieve myocardial recovery.
Explore clinical data that validates best practices in AMI cardiogenic shock management.